RCMI Coordinating Center (RCMI CC) Header Logo

Design and discovery of a high affinity, selective and ?-arrestin biased 5-HT7 Receptor Agonist.

Onyameh EK, Ofori E, Bricker BA, Gonela UM, Eyunni SVK, Kang HJ, Voshavar C, Ablordeppey SY. Design and discovery of a high affinity, selective and ?-arrestin biased 5-HT7 Receptor Agonist. Med Chem Res. 2022 Feb; 31(2):274-283.

View in: PubMed

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support